IN8Bio

1 follower

IN8bio, Inc. (“IN8bio”) is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancers by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Employees

11-50

Links


Org chart

William Ho
President, CEO & Director, Co-founder
Collapse
Kate Rochlin
President & Chief Operating Officer
Lawrence Lamb
Executive Vice President and Chief Scientific Officer
Patrick McCall
Chief Financial Officer
Kate Rochlin
President & Chief Operating Officer
Lawrence Lamb, PhD
Executive Vice President And Chief Scientific Officer

Board & advisors